Perampanel Suspension
NDC Package 51672-4256-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Perampanel suspension is perampanel is used to treat certain types of seizures (including focal and generalized tonic-clonic seizures). This formulation utilizes a suspension delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-4256 and is authorized under FDA application ANDA219052.

Identification & Billing

NDC Package Code
51672-4256-9
Package Description
1 BOTTLE in 1 CARTON / 340 mL in 1 BOTTLE
Product Code
51672-4256
11-Digit Billing Format
51672425609

Clinical Specifications

Proprietary Name
Perampanel
Non-Proprietary Name
Perampanel
Substance Name
Perampanel
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PERAMPANEL .5 mg/mL
Pharmacologic Class
Usage Information
Perampanel is used to treat certain types of seizures (including focal and generalized tonic-clonic seizures). Perampanel belongs to a class of drugs known as anticonvulsants.
DEA Schedule
Schedule III (CIII) Substances

Regulatory & Marketing

Labeler Name
Sun Pharmaceutical Industries, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA219052
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-16-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51672-4256-9 identifies a specific commercial package of 1 bottle in 1 carton / 340 ml in 1 bottle of Perampanel, a human prescription drug labeled by Sun Pharmaceutical Industries, Inc.. This suspension is formulated for oral use and contains perampanel as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on June 16, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Perampanel is used to treat certain types of seizures (including focal and generalized tonic-clonic seizures). Perampanel belongs to a class of drugs known as anticonvulsants.

How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672425609. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51672-4256-9
11-Digit CMS (5-4-2)
51672-4256-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.